Search This Blog

Wednesday, April 6, 2022

FDA advisers weigh boosters’ fate

 The Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee met on Wednesday along with other health officials and experts from around the world to discuss the future of how the U.S. will handle the SARS-CoV-2 virus as cases dwindle and the necessity of future doses is debated.

The all-day meeting was dedicated to discussing boosters and how future strains of the coronavirus will be addressed. The committee did not hold any votes and the exact details of future vaccine compositions and rollouts were not specified.

Peter Marks, director for the Center for Biologics Evaluation and Research, noted during the meeting that despite the declining COVID-19 cases in the U.S., the virus will continue to mutate and could still cause waves of cases in the future.

Specifically, Marks pointed to three factors that put the U.S. at risk of another surge in the fall and winter of this year: waning immunity, particularly among those who have never been vaccinated or haven’t been boosted; an ever-changing virus that will have had six months to mutate; and colder temperatures driving people to stay indoors.

Another challenge in planning for the future of the SARS-CoV-2 virus is the uncertainty of what sorts of strains will develop. Trevor Bedford, a researcher at the Fred Hutchinson Cancer Center’s Vaccine and Infectious Disease Division, noted the remarkable speed at which COVID-19 has mutated, especially when compared to the influenza virus.

Bedford noted that faster influenza strains typically take three to five years for a new strain to emerge, while COVID-19 led to numerous strains emerging within the span of only one year.

“We can maybe expect it to slow down as things stabilize a bit, but this to me suggests a fairly adaptable and evolvable protein that is likely to keep on evolving in response to selective pressure,” he said.

When it came to the more immediate causes of concern, such as the BA.2 variant that has caused cases to rise in Europe and Asia, health experts said it would likely not have a significant impact on the U.S.

Christopher Murray, director of the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, noted the BA.2 COVID-19 variant appeared to result in a rise in cases that only lasts about three weeks.

According to modeling from the IHME, the BA.2 strain likely won’t have a large impact on the U.S. However, Murray also noted that community-wide immunity in the U.S. appeared to have peaked some time in February, with protection now currently declining slightly.

The health experts also thoroughly discussed the process in which influenza strains are chosen for the annual flu vaccine and how this vaccine development model could lend itself to the coronavirus.

Jerry Weir, director of the FDA’s Division of Viral Products, noted that the current model with which flu vaccines are developed works well because influenza strains have predictable change, the vaccines have similar platforms and new clinical data is usually not needed for new flu vaccines due to the predictability of strains.

However, the pandemic has shown repeatedly that the COVID-19 virus is not predictable like influenza and the FDA currently requires clinical effectiveness and safety data for modified vaccines.

Throughout the meeting, the health experts repeatedly acknowledged the uncertainty that still pervades the numerous factors of the COVID-19 pandemic.

“What really keeps me up at night is the knowledge that we can’t keep boosting and that we only — we’re gonna have vaccine exhaustion. And I’m not talking about immune exhaustion, I’m talking about physical exhaustion of people not going to get boosted,” Marks said.

https://thehill.com/policy/healthcare/3260667-fda-advisers-meet-to-weigh-future-of-booster-doses-possible-new-strains/

COVID-19 cases among key DC players jump after Gridiron

 At least five high-profile Washington players have tested positive for COVID-19 after attending the star-studded Gridiron Club dinner last weekend, one of whom is considered a close contact of Vice President Harris

Harris’ Communications Director Jamal Simmons, Attorney General Merrick Garland, Commerce Secretary Gina Raimondo, and Reps. Adam Schiff (D-Calif.) and Joaquin Castro (D-Texas) have all tested positive for breakthrough COVID-19 cases after attending Saturday night’s event.

A number of journalists, White House staffers and personnel from the National Security Council have also tested positive for the virus after attending the dinner, according to The Washington Post. The newspaper, however, did not identify the individuals because they have not publicly announced their COVID-19 status.

Attendees at Saturday night’s dinner were required to show proof of vaccination, according to Gridiron President Tom DeFrank of the National Journal.

“All guests at the Gridiron Club dinner were required to show proof of vaccination. We understand that some of our guests have reported positive tests since the dinner. We wish them a speedy recovery,” DeFrank told The Hill in a statement.

The Gridiron Club dinner returned to Washington this weekend after a two-year hiatus because of the COVID-19 pandemic. The event is one of several high-profile annual gatherings in the nation’s capital, featuring skits and roasts knocking politicians and other figures.

The president typically attends the white-tie fete, but President Biden did not make an appearance this year, instead recording a video for the dinner. Biden last tested negative for COVID-19 on Monday, according to the White House.

A number of other congressional lawmakers and administration officials, including Agriculture Secretary Tom Vilsack, special presidential envoy John Kerry and Federal Reserve Chairman Jay Powell attended the event, according to the Post. Dr. Anthony Fauci, Centers for Disease Control and Prevention (CDC) Director Rochelle Walensky and White House press secretary Jen Psaki were also reportedly in attendance.

Simmons is the latest individual to test positive for COVID-19 following the event. Kirsten Allen, the vice president’s press secretary, said Simmons tested positive on Wednesday, and was in close contact with Harris. The vice president as a result will follow CDC guidance and consult with her physician but plans to make no changes to her public schedule.

Most individuals who tested positive following the dinner said they were experiencing mild or no symptoms. Garland took part in a press conference with other law enforcement officials on Wednesday, including FBI Director Christopher Wray and Deputy Attorney General Lisa Monaco, hours before the Justice Department announced his positive test.

The Justice Department told The Hill that Monaco took a COVID-19 test out of an abundance of caution, and tested negative. New Hampshire Gov. Chris Sununu (R), who spoke at Saturday’s dinner, also took a COVID-19 test as a precaution and tested negative.

The rise in cases among Washington’s top players following Saturday night’s event is raising questions regarding the country’s return to a new, normal version of pre-pandemic life after more than two years of various restrictions and mitigation measures.

Few dinner attendees wore masks Saturday evening, people at the event told the Post. Washington, D.C., lifted its mask mandate for businesses on March 1.

https://thehill.com/policy/healthcare/3261010-covid-19-cases-among-key-dc-players-jumps-after-gridiron-dinner/

Kintor’s Antiviral Demonstrates Broad Protection in Mild to Moderate COVID-19

 Suzhou, China-based Kintor Pharmaceutical announced topline results from its Phase III MRCT trial of proxalutamide in outpatients with mild to moderate COVID-19. The study evaluated the patients regardless of vaccination status or risk factors.

The data demonstrated that the drug, when given to the patients for more than seven days, offered a protection rate of 100%. It reduced hospitalization or death in COVID-19 patients, notably in the middle-aged and elderly with high-risk factors.

Proxalutamide is an ACE2 and TMPRSS2 inhibitor. ACE2 is the primary receptor on human cells that allows the SARS-CoV-2 virus to latch on and enter the cell. The virus uses TMPRSS2 for S protein priming, which is to say, it activates the virus’s S protein. Inhibiting both of these protein receptors stalls the virus’s ability to enter and infect cells. And by promoting the clearance of the virus it decreases inflammation by activating the Nrf2 pathway, which prevents overproduction of IL-6, proinflammatory cytokines and chemokines.

“The topline data of this pivotal study demonstrates the clinical efficacy of proxalutamide in the mostly U.S. COVID-19 population with a significant reduction of hospitalization and death rate in patients,” stated Dr. Tong Youzhi, founder, chairman and chief executive officer of Kintor.

Youzhi went on to say, “It is important to note that proxalutamide has showed COVID-19 viral load reduction against both Delta and Omicron variants, which is important as new variants continue to arise. The continued increase in COVID-19 cases serves as a reminder that the world urgently needs effective and safe oral drugs with different mechanisms of action.”

The company plans to apply for emergency use authorization in the U.S., and the equivalent in China and other countries.

The clinical trial enrolled 733 participants with a positive COVID-19 test and symptoms onset regardless of vaccination status or other risk factors. Of them, 99% were recruited in the U.S. Participants received either 200mg of proxalutamide once-a-day plus standard of care (SOC) or placebo plus SOC for 14 consecutive days.

The endpoints included percentage of patients who were not hospitalized for any reason for at least 24 hours, or who did not require supplemental oxygen for at least 24 hours in response to SpO2 ≤93 and who were alive by Day 28; the percentage of patients with all-cause hospitalization requiring supplemental oxygen or all-cause death by Day 28; and changes of SARS-CoV-2 viral load from baseline to Day 28.

The drug was well tolerated with manageable side effects in the patient populations. Kintor found treatment-related adverse events were comparable to the control group, with the majority of treatment-emergent adverse events (TEAE) being mild. The most common side effect was dizziness. No serious adverse events were observed.

Of all patients in the trial who received at least one day of treatment, eight who received placebo were hospitalized, with one death, versus four patients hospitalized in the proxalutamide group with zero deaths. All hospitalizations were related to COVID-19. The drug decreased the risk of hospitalization or death by 50% compared to the control group.

In patients who received treatment with the drug for more than one day, seven patients in the placebo group were hospitalized including one death, compared to two patients who received proxalutamide, with, again, zero deaths. In this longer-treatment group, the drug reduced the risk of hospitalization or death by 71% compared to the control cohort.

And in patients who received treatment for more than seven days, six in the placebo cohort were hospitalized with one death compared to no hospitalization or death in the proxalutamide cohort. In this group, proxalutamide decreased the risk of hospitalization or death by 100% compared to the placebo cohort.

In terms of comorbidities and age, in patients 50 years or older who were obese, the drug reduced the risk of hospitalization or death by 100%. In patients 60 years or older with or without underlying medical conditions, proxalutamide also reduced the risk of hospitalization or death by 100%. And in patients 60 years or older who had at least one underlying medical condition, such as obesity, diabetes or hypertension, there were no hospitalizations or deaths in the group receiving the drug.

Proxalutamide would appear to be on track for authorization, to join Pfizer’s Paxlovid (nirmatrelvir; ritonavir) and Merck and Ridgeback Biotherapeutics’ Lagevrio (molnupiravir) as effective oral antiviral treatments for mild to moderate COVID-19.

https://www.biospace.com/article/kintor-s-antiviral-demonstrates-broad-protection-in-mild-to-moderate-covid-19/

Discovery of New Lung Cell Could Lead to Breakthroughs in COPD

 An article published in Nature is sure to ripple through the scientific and medical community, as anatomical discoveries often do. Researchers at the Perelman School of Medicine at the University of Pennsylvania have discovered a novel type of cell buried in healthy human lung tissue. The cells have been given a new name, respiratory airway secretory (RAS) cells, to describe one of the unique roles that they fulfill.

The revelation was made when the team at Perelman looked for an alternative model to the typical mouse lung, to better understand the anatomical nuances of lung bronchioles, and further expand their understanding of conditions affecting the lungs. While markedly similar, the mouse lung anatomy is a small-scale model riddled with differences from the human lung. Thus, respiratory anatomy could not be completely mapped. The move to refocus on donated healthy human tissue proved to be key.

Given the namesake, it is easy to discern that researchers have discovered that the cells secrete a fluid that is critical for lung cell maintenance. The fluid coats the bronchial lining, increasing the efficiency of the delicate airways that transmit air to the lungs. Additionally, RAS cells appear as undifferentiated, progenitor cells that can specialize into alveolar type 2 cells through the notch and Wnt signaling pathway when necessary. Alveolar type 2 cells are essential for protecting and repairing alveolar cells, which expand the surface area available for gas exchange.

To explore the ways in which RAS cell understanding can be applied, the research expanded to those diagnosed with chronic obstructive pulmonary disease (COPD). The disease inflames and impairs the lungs and airways surrounding the lungs, leaving a patient unable to breathe properly. A COPD diagnosis could later turn into an emphysema diagnosis, with anti-inflammatory drugs the only option available to mitigate symptoms.

Researchers suspect that, compared with healthy lung tissue, the lungs of a COPD patient will have damaged RAS cells. If correct, the damage can be examined it relates to RAS cell functionality, enabling research that could lead to groundbreaking treatments. Understanding the restorative abilities of RAS cells could lead to reversing inflammatory damage or death of alveoli cells contributing to COPD progression.

One of the article’s authors and a professor at Perelman, Edward E. Morrisey describes the novel terminology gifted to the cells:

“RAS cells are what we've termed facultative progenitors, which means they act as both progenitor cells and also have important functional roles in maintaining airway health.”

Data from 1999 to 2019 presented by the U.S. Centers for Disease Control and Prevention indicates that, in both male and female populations, deaths attributed to COPD are on a downward trend. This may be a result of widespread understanding that smoking diminishes health, whereas cardiovascular activities maintain respiratory strength.

The presence of RAS cells has been seen in mammals as small as ferrets, but further research must be done to know how many species have these fascinating cells. The scientific community is sure to pounce on novel research opportunities that utilize the regeneration observed in RAS cells, while the medical community and COPD patients have been issued a strong dose of hope.

https://www.biospace.com/article/new-type-of-lung-cell-could-lead-to-breakthroughs-in-copd/

Leaked Recording Of Shanghai CDC Describes Chaos Behind Lockdown

 by Li Jing and Luo Ya via The Epoch Times (emphasis ours),

While Shanghai continues its lockdown and massive PCR testing campaign as COVID-19 surges through the city, a CDC expert’s complaint about chaotic PCR test reports that have confused people was recently exposed online. Shanghai CDC issued a notice demanding staff answer public inquiries “in line with the policy.”

There have been complaints about the conflicting PCR test results on Chinese social media because people receive a negative test result on their cell phones but then receive a positive test result from the CDC.

Shanghai adopted the Healthcare Cloud app as its integrated Internet and Healthcare services platform. Locals register through the app for a PCR test and receive the test result on their cell phones. However, many people received a negative test notice via the app but still were then notified by CDC that they had tested positive and were thus subject to quarantine.

Complaints have flooded the Shanghai CDC hotline.

A recently leaked recording of a CDC expert responding to a caller revealed how the app has been problematic, how overloaded health workers have been stymied by a lack of transparency in pandemic prevention, and how the pandemic has become a political issue.

The Test Negative Is Fake

In the recording, the expert said, “We have received hundreds of calls every day, but our jobs are epidemiological investigations. We can’t solve your problem.”

She said, “Let me tell you the facts: There’s no ward, the quarantine sites are filled, and there’s no ambulance.”

A male was heard complaining, “But we have no way to address our issue, even Weibo is blocked.”

The expert said, “I have brought this up too many times; as an expert, I have suggested that the mild to no symptom patients stay at home. Does anyone listen? No!”

She continued, “Let me reiterate, do not bother checking your health cloud, it’s all a negative result. Only we will notify you when you have tested positive.”

The caller responded, “So what we see is all fake?”

She said, “That’s right.”

In the recording, the expert encouraged making public the recording.

In this photo released by China’s Xinhua News Agency, people with mild and symptomatic cases of COVID-19 quarantine at the Shanghai New International Expo Center in Shanghai, on April 1, 2022. (Ding Ting/Xinhua via AP)

A Pandemic Turns Political

The expert explained that she had complained to her leader that CDC staff should not be contacting people about their testing positive while people have received a negative test message on the app. It has only exhausted the staff at the CDC and confused the public.

She said, “We, as the professionals, are pushed to the brink of collapse by the situation. This pandemic has become a political issue that’s consuming so much manpower, resources, and money, just to solve this flu-like disease. What other country do you think is doing this kind of epidemic prevention now?”

The expert also suggested to the caller, “The quarantine site is not up to standard, and there’s no medical service at the site. If you are forced to go to the isolation ward, ask them for proof of a positive test result before they can enforce it. Let me tell you, they won’t have it.”

After the recording was leaked, multiple online articles confirmed that the Shanghai CDC expert was Zhu Weiping, director of the Infectious Disease Prevention and Control Section of Shanghai Pudong New Area CDC. The Epoch Times has not been able to independently verify the authenticity of the recording.

According to the Chinese articleher comments drew criticism from those who support the communist regime, calling it a serious political incident—an advocate of “coexistence with the virus,” an aggressive attack on the party, and sabotaging and shaking the anti-epidemic deployment. Many netizens have supported her saying “protect Zhu Weiping.”

The leaked recording was soon deleted from the Chinese internet.

At the same time, the Shanghai CDC issued a notice to relevant departments demanding the hotline to be answered only by trained staff, and answers should be provided only in line with the current policy.

On March 28, Shanghai imposed a two-stage lockdown of four days, first for the eastern side of the city, and then the western side of the city, divided by the Huangpu River, with two rounds of nucleic acid tests, until April 5.

The city decided on April 4 to extend the lockdown with no known date to lift the restriction that affects more than 26 million people in the city.

Mary Hong contributed to this report.

https://www.zerohedge.com/covid-19/pushed-brink-collapse-leaked-recording-shanghai-cdc-expert-describes-chaos-behind-lockdown

Citing Racial Discrimination, Black Leaders Target Roe v Wade

 by Alex Newman via The Epoch Times (emphasis ours),

A major lawsuit on behalf of unborn black babies making its way through the courts in Alabama has legal abortion in the crosshairs, alleging that the abortion industry is deliberately targeting black Americans and other minorities.

If successful, the attorneys and activists behind the case told The Epoch Times that it might ultimately overturn Roe v. Wade, the 1973 precedent-setting U.S. Supreme Court opinion that struck down state laws against abortion.

Even if the case does not succeed in court, legal analysts and experts in the field say the implications for the court of public opinion are hard to overstate.

The lawsuit was filed by pro-life leader Amie Beth Shaver, named Miss Alabama in 1994, on behalf of “Baby Q,” an African American baby in Alabama who was unborn when the case began. Baby Q represents all other similarly situated black babies in the womb across the state.

According to the complaint, Baby Q and other members of the “class” are being unlawfully discriminated against and targeted for abortion by the industry. Abortion giant Planned Parenthood acknowledges its roots in the eugenics movement, but says it is working to rectify that legacy.

About 80 members of Baby Q’s class, which is African American babies in the womb, lose their lives in abortion every week in Alabama,” Sam McClure, the lead lawyer representing the babies, told The Epoch Times in a phone interview. “Enough is enough. This has to stop.”

Several leaders involved in the case told The Epoch Times that Planned Parenthood and the abortion industry more broadly have a long history of racism and support for eugenics, the highly controversial idea that humanity should be “improved” by weeding out allegedly inferior genes from the population.

“This case really boils down to the question of whether states have the right to prohibit eugenics abortion,” added McClure.

Many of the black leaders involved in the case were also behind the Equality Proclamation, signed in 2020 on the 158th anniversary of the Emancipation Proclamation, to shine the spotlight on what they describe as the systematic targeting of black babies.

Why Alabama?

Conservative Alabama is the best jurisdiction in America to wage this fight, McClure said.

Thanks to a measure approved by around 60 percent of voters in 2018, Alabama has one of the strongest protections for the unborn in its state Constitution. It says the policy of the state is “to recognize and support the importance of unborn life and the rights of unborn children, including the right to life.”

The Alabama Supreme Court has repeatedly recognized the personhood of unborn babies in other cases not directly involving abortion, McClure and other attorneys involved in the case told The Epoch Times.

The Baby Q case also hinges on a state law known as the Human Life Protection Act, which makes committing an abortion a felony punishable by up to life in prison.

Signed into law by Governor Kay Ivey in May of 2019, the measure bans all abortions in the state except to protect the health and life of the mother.

That law is widely seen as one of the strongest in the nation prohibiting abortion. It is even stronger than the Mississippi statute currently being considered by the U.S. Supreme Court in Dobbs v. Jackson Women’s Health Organization, a case many legal experts on both sides of the debate believe could overturn or at least scale back Roe v. Wade.

In October of 2019, a federal court issued a preliminary injunction against the Alabama law, arguing that it violates existing Supreme Court precedent.

As a result, Ivey and Alabama Attorney General Steve Marshall have declined to enforce it, for now, as the U.S. Supreme Court once again takes up the issue of abortion.

Legal filings and attorneys in the Baby Q case also point to the Ninth Amendment to the U.S. Constitution, which protects unenumerated rights, as well as the Fourteenth Amendment providing for equal protection under the law.

Finally, plaintiffs in the case cite the U.S. Constitution’s Tenth Amendment, which reserves to the states or the people all powers not specifically surrendered to the federal government, as authorizing or even requiring state action in defense of the right to life.

Intervening in the case on behalf of Baby Q are almost 50 state lawmakers and a supermajority of the state Senate, as well as dozens of black leaders from across America alleging that the abortion industry is targeting people based on race.

State GOP leaders are also active on the issue, with the executive committee calling on all Republican officials to use every tool at their disposal to stop abortion in Alabama, including shutting down clinics.

The Objective

The Baby Q case, originally filed in October of 2020, is aimed at forcing the government “to protect preborn African-American children from discrimination and to ensure their equal protection under the law,” according to court filings.

“The abortion industry has systematically targeted the African American community for extermination by abortion, and this history is undisputed,” said attorney McClure, citing historical evidence and even recent statements.

Over 20 million black babies have been aborted in America so far, and are three to five times more likely to be aborted than white babies, continued McClure. This sort of racial targeting is clearly prohibited under state and federal law, he added.

“In New York City, more black babies are killed in abortion than are born alive,” he continued. “In Alabama, black Americans make up 27 percent of the population, and yet they make up more than 60 percent of the abortion cases. Nobody can argue that this is not deliberate.”

The plaintiffs in the case are asking the court to order Gov. Ivey to enforce the Human Life Protection Act and protect unborn children in the state from abortion and discrimination based on their race.

Eventually, the goal is to completely overturn Roe v. Wade and restore protections for the unborn that the landmark Supreme Court case undermined nearly 50 years ago.

Because equal protection and prohibitions on racial discrimination are so firmly established in American jurisprudence, the activists and attorneys behind the case believe it could be a game changer in the abortion debate.

The next major milestone will come on April 20, when the judge will hold a hearing on the issue after more than a year of no action on it.

“Finally, on April 20th, these African American babies are going to get their day in court,” said McClure.

The previous hearing, which took place on Zoom, dealt with whether the case should be public. The abortion industry is seeking to keep it behind closed doors, but the state judge expressed a willingness to having it in the open.

Attorney Brent Helms, who is representing the legislators seeking to intervene in the case, explained part of the rationale in a phone interview with The Epoch Times.

“If the judge denies this case, that offers us the opportunity to get to the Alabama Supreme Court,” he said.

“When the legislature looks at this case, Alabama’s law is more strict and says that the unborn child is a person with constitutional rights,” Helms continued. “Those rights cannot be denied without due process and equal protection.”

Helms added: “That means the child’s right to life would supersede or at least compete with the mother’s alleged right to privacy, as the right to life is an enumerated right, while the mother’s privacy rights to obtain an abortion were discovered in the penumbras as opposed to actually being written down.”

Regardless of how the state circuit court judge rules, the losing side is expected to immediately appeal to the Alabama Supreme Court. The court is known as one of the nation’s more conservative state supreme courts.

From there, it is practically certain that the losing side will appeal directly to the U.S. Supreme Court.

The Role of the US Supreme Court

Numerous legal experts told The Epoch Times that the courts involved in the Alabama case may wait until the U.S. Supreme Court rules on the Mississippi law banning abortions after 15 weeks before making any major decisions.

However, the Mississippi statute only protects unborn babies after 15 weeks, while Alabama is seeking to protect them from the time of conception. The Baby Q case also deals with racial discrimination, while the Mississippi case does not.

The plaintiffs and intervenors hope the apparent conflict between the Alabama State Supreme Court’s positions and the federal district court’s rulings will be settled by the U.S. Supreme Court in favor of protecting the right to life of the unborn in Alabama and beyond.

McClure, the lead attorney for Baby Q, said justices from the Supreme Court have been leaving “breadcrumbs” in their opinions regarding what elements they would like to see in a major abortion case.

In his concurring opinion issued in the case of Box v. Planned Parenthood, for example, Justice Clarence Thomas raised the issue of racial targeting as an important component.

“We think the type of case the U.S. Supreme Court wants to take on to return abortion issues back to the states involves eliminating the abortion industry’s history of racial targeting, a purely state law claim, and a reliance on the Ninth Amendment of the U.S. Constitution,” McClure said, noting that the Baby Q case had all of those.

Obviously, we care about all life in the womb, but this case in particular deals with the racial targeting of children of African descent and this is a key issue,” he added.

The U.S. Supreme Court’s own 1973 ruling on abortion acknowledged that if the “suggestion of [a fetus’] personhood is established, the appellant’s case, of course, collapses, for the fetus’ right to life would then be guaranteed specifically by the [Fourteenth] amendment.”

The people of Alabama, as well as many medical and scientific experts, have concluded that unborn children are indeed persons, attorneys and leaders involved in the case said. Thus, under the reasoning in Roe v. Wade, the high court must act.

The hope is that, through the courts, the abortion industry can be prevented from targeting unborn persons based on race, and eventually, state governments can regain the authority to protect all unborn lives, McClure said.

Racism in Planned Parenthood and Abortion

Dozens of prominent black leaders from across America are involved in the case, arguing that Planned Parenthood and the abortion industry have been deliberately targeting the nation’s African American population and other minorities.

It started at the very beginning with Margaret Sanger, the founder of Planned Parenthood, black leaders told The Epoch Times.

In her writings and her speeches to groups such as the Ku Klux Klan (KKK), Sanger openly advocated for eugenics to control the reproduction of populations she believed were less desirable.

Indeed, in 1939, Sanger launched the infamous “Negro Project” to pay and train black leaders to promote birth control and other measures in the black community.

Eventually, when Alan Guttmacher took the helm of Sanger’s organization, abortion became a major element of the campaign, Georgia gubernatorial candidate and Baby Q intervenor Catherine Davis told The Epoch Times in a phone interview.

After Guttmacher and his allies were able to get the Supreme Court to strike down state laws protecting the unborn, “Planned Parenthood established their abortion clinics primarily in communities of color across America,” Davis said.

Among other evidence, she pointed to an investigation using 2010 Census data showing that about 80 percent of the organization’s abortion clinics were located in minority neighborhoods.

Planned Parenthood would claim that their clinics are located where there is “the greatest need,” said Davis.

“But if you look at their marketing, they are regularly targeting black Americans,” she added. “On Halloween they even tweeted out that it was safer for a black woman to have an abortion than to carry the baby to term. This is outrageous.”

According to Davis and the dozens of other black leaders involved in the case, this is racist population control and eugenics.

“The closest example of this is what Hitler did in Nazi Germany,” she added. “Look at Planned Parenthood: this is exactly what Hitler was doing to Jews, but Sanger’s program was more successful because they take care to disguise their agenda as ‘helping’ women and protecting their ‘right’ to abortion.”

Another prominent leader involved in the case, Martin Luther King’s niece and pro-life leader Alveda King, called this battle “the civil rights issue of our time.”

“No racial group in America has ever been more left out of societal protection nor suffered more deliberate discrimination, dehumanization, agonizing dismemberment, and death legally imposed upon them than black children,” said King.

“The Baby Q case is a gauntlet,” King told The Epoch Times in an email. “Pray that the hammer of justice will rule in favor of life.”

The controversial racial component of abortion was also highlighted nationally in the 2009 documentary “Maafa 21: Black Genocide in 21st Century America,” which argued that the targeting of black Americans in abortion constitutes a genocide.

Planned Parenthood Confesses, Data Speaks Too

In recent years, as the Black Lives Matter movement gained prominence, almost 20 Planned Parenthood affiliates with operations across 3 out of 4 states have issued public admissions of racism within the organization.

Planned Parenthood of Greater New York, for instance, condemned Planned Parenthood founder Sanger’s “racist legacy” while announcing that her name would be removed from its building.

“There is overwhelming evidence for Sanger’s deep belief in eugenic ideology,” the group said. “Removing her name is an important step toward representing who we are as an organization and who we serve.”

Planned Parenthood of Pacific Southwest, meanwhile, acknowledged “white supremacy of the past and present,” including “our own organization” and the “implicit bias” that it said still exists within Planned Parenthood today.

Planned Parenthood has been complicit in upholding systemic racism,” the group’s Illinois affiliate said.

Similar statements confessing to “present participation in white supremacy” and acknowledging that Sanger’s “racist ideals” have “shaped Planned Parenthood today” were issued by numerous other affiliates.

And yet the massive disparities continue, advocates say. According to a legal filing by black leaders in the Baby Q case citing state health statistics, 63 percent of the 7,538 “unborn children killed by abortion providers in Alabama” in 2019 were black.

This shows abortion providers “intentionally target African American children,” the black leaders said in the legal filing. And this “violence” based on race would never be tolerated in any other context, they argued.

Where the Case Goes Now

Later this month, a hearing on the case will be held in state court in Alabama to hear arguments from the various parties involved.

In its response to the lawsuit, Planned Parenthood Southeast asked the court to dismiss the case based on lack of jurisdiction and Baby Q supporters’ alleged failure to identify a claim where the court would be able to provide relief.

Neither the national Planned Parenthood office nor the Southeast office responded to requests for comment from The Epoch Times on the allegations of racism or the ongoing litigation.

The governor’s office is taking the same position as the abortion industry, urging the court to dismiss Baby Q’s case and refuse to allow legislators behind the Human Life Protection Act to intervene.

Gov. Ivey’s office did not respond to requests for comment on why the governor has declined to enforce the Human Life Protection Act or why she is asking the court to dismiss the case.

Attorney General Steve Marshall’s office also did not respond by press time.

Colonel John Eidsmoe, a prominent constitutional scholar in Alabama who has worked closely with multiple state Supreme Court justices, told The Epoch Times that he did not anticipate a ruling by the Alabama courts until after the U.S. Supreme Court issues its opinion in the Mississippi case. That ruling is expected by this summer.

“The general feeling is that the Supreme Court will uphold the Mississippi law, but it is not clear yet whether it will overturn or simply modify Roe v. Wade,” added Eidsmoe, a professor of Constitutional Law at Oak Brook College of Law & Government Policy as well as senior counsel for the Alabama-based Foundation for Moral Law.

Alabama’s Supreme Court, he said, would likely want to wait for a favorable decision from the U.S. Supreme Court on the Mississippi law before moving on this.

Eidsmoe also believes that, with its current makeup, the U.S. Supreme Court would be likely to uphold Alabama’s law protecting the unborn as well.

Potentially even more important than the legal issues is what this case could do in the court of public opinion, said Eidsmoe.

If Americans broadly recognize the facts in the abortion controversy and especially the racial targeting, the political and cultural implications would be beyond profound.

Multiple experts and leaders involved in the case told The Epoch Times that these may be the last days for Roe v. Wade, legal abortion, and racial targeting of minorities by the industry. The outcome of the Baby Q case may play a key role in that historic shift.

https://www.zerohedge.com/medical/citing-racial-discrimination-black-leaders-target-roe-v-wade

Glaxo Study Shows Covid-19 Patients Over 50 at Greater Risk for Shingles

 GlaxoSmithKline Plc said a study it conducted showed people age 50 or older in the U.S. who have had Covid-19 may be at greater risk of developing shingles compared with those who haven't been diagnosed with Covid-19.

The company said that in this retrospective cohort study, people aged 50 or older who contracted Covid-19 were 15% more likely to develop shingles compared with controls who were never diagnosed with Covid-19.

The risk of shingles was elevated for up to six months after a Covid-19 diagnosis. People hospitalized for Covid-19 were 21% more likely to develop shingles.

The study observed adults aged 50 years and older using claims data from two large U.S. databases and matched persons with and without Covid-19 using various known shingles risk factors. Anyone vaccinated against either shingles or Covid-19 was excluded from the cohorts.

Glaxo said the results highlight the importance of preventative measures, such as vaccination, to protect the health and wellbeing of older adults who are at risk for vaccine-preventable diseases like Covid-19 and shingles.

Shingles, also known as herpes zoster, is caused by a reactivation of the varicella zoster virus--the same virus that causes chickenpox--which lays dormant in the body after the initial infection. Nearly all adults over age 50 carry the virus that causes shingles. Natural age-related decline of the immune system can allow VZV to resurface, causing shingles. People with a suppressed or compromised immune system also are at increased risk of developing shingles.

The study authors, as well as case report publications, suggest that Covid-19 could trigger shingles by disrupting immune cells, allowing VZV to reactivate. Glaxo said more research is needed to confirm this hypothesis.

https://www.marketscreener.com/quote/stock/GLAXOSMITHKLINE-PLC-9590199/news/GlaxoSmithKline-Study-Shows-Covid-19-Patients-Over-50-at-Greater-Risk-for-Shingles-39982571/